Skip to main content
Quest Diagnostics

Whitepaper

IVD Predicate Device Whitepaper

Selecting a lab partner for your 510(k) submission: 9 Key Considerations 

This whitepaper explores 9 key considerations IVD manufacturers should ask when selecting a lab testing partner, along with Quest’s responses. 
Device.

Many IVD manufacturers know Quest Diagnostics as one of their largest customers. In fact, as the largest diagnostic lab in the country, we utilize instrumentation from nearly every IVD company in the market.

When IVD manufacturers develop new assays, they typically need to perform predicate device studies during the development and validation of new diagnostic tests. A predicate device study involves comparing the performance of a new test to that of a previously approved or cleared device that serves as a reference or "predicate" for the new device. The purpose of this study is to demonstrate that the new test is substantially equivalent to the predicate device in terms of performance, safety, and effectiveness.

This whitepaper is free and can be downloaded and read at your convenience.

632

* indicates required

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.